Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-22

Clinical Trial Update: Actinic Keratoses Treated With 5-fluorouracil Plus Aluminum [Phase 1]

View source ↗

Summary

An ongoing Phase 1 clinical trial is evaluating the safety of a topical regimen combining 5-fluorouracil with aluminum for actinic keratosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Fluorouracil (5-FU)

Snippet

Sponsor: West Virginia University | Conditions: Actinic Keratoses | Phase 1 | Status: RECRUITING